Stimulation by insulin of cyclic AMP phosphodiesterase. Role of glutathione-insulin transhydrogenase

Participation of cellular thiol/disulphide groups in the uptake, degradation and bioactivity of insulin in primary cultures of rat hepatocytes

The effects on the uptake (cell-associated 125I) and degradation (125I-labelled products released into the medium) of 125I-insulin and bioactivity (protein, glycogen and lipid synthesis) of insulin caused by altering the cellular thiol/disulphide status in primary cultures of rat hepatocytes were studied. Incubation of hepatocyte cultures with various exogenous thiol compounds (reduced glutathione, 2-mercaptoethanol, cysteamine, dithiothreitol) resulted in increased insulin binding, but markedly decreased degradation and bioactivity. These effects could be reversed by washing or by the addition of oxidized glutathione, which alone had no effect. When cultures were exposed to certain thiol-modifying reagents (N-ethylmaleimide, p-chloromercuribenzoate, p-chloromercuribenzenesulphonate, iodoacetamide, iodoacetate), some decreases in bioactivity were evident, but the pronounced decrease in insulin degradation observed with the thiol-containing compounds was not observed with this class of compounds. None of the thiol-containing or -modifying agents tested had any significant effect on cellular ATP concentrations, indicating that the effects observed were due to perturbation of the thiol/disulphide status. Depletion of intracellular glutathione by DL-buthionine SR-sulphoximine (a specific inhibitor of glutathionine biosynthesis) decreased the syntheses of glycogen and lipid by about one-half, while having essentially no effect on protein synthesis, ATP concentrations or on the binding and degradation of insulin. The data presented here indicate that although intracellular thiol (glutathione) concentrations may be important for the maintenance of full expression of certain biological activities (glycogen and lipid synthesis), the thiol/disulphide groups on the cell surface and those immediately inside the cell membrane may be more critical in the mediation of insulin action, including the degradation and bioactivity of insulin in primary cultures of rat hepatocytes.

Binding, degradation, and bioactivity of insulin in primary cultures of rat hepatocytes

Hepatocytes from fasted rats, previously maintained as a monolayer in a serum-free glucagon-containing culture medium are demonstrated to provide a useful model system for the study of receptor-mediated mechanisms of insulin action. The cultured liver cells show glucagon- and insulin-responsive biological effects. These cultures show the long-term effects of insulin on the syntheses of protein ([3H]leucine incorporation), glycogen, and lipids (conversion of [3H]glucose) in a dose-dependent manner in the physiological range of insulin concentrations. The order of the effects of different analogues of insulin on each of the bioactivities studied at 37 degrees C is the same as their order to compete at 25 degrees C for binding to insulin-specific receptors. The characterization of radioactive products of 125I-insulin using gel filtration and anti-insulin A chain antibody has shown a transient accumulation of insulin A chain, indicating that the sequential pathway of insulin degradation is operative in the anchored, cultured hepatocytes. Whereas the synthesis of proteins proceeds linearly after insulin inoculation, the syntheses of glycogen and lipids first occur after a lag period of about 10 and 12 h, respectively. None of the three 125I-labeled fragments or products of 125I-insulin released in the culture mediums showed any biological activity (glycogenesis) in cultured hepatocytes although a high-molecular-weight 125I-product isolated from cells could not be tested because of its insolubility. The possibility that the insulin effects might have been mediated via a nonradioactive fragment of insulin or another chemical agent remains open.

Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats

Platelet aggregation and cyclic nucleotide (cNCL) phosphodiesterase (PDE) have been studied in a new strain of insulin-dependent spontaneously diabetic rat (SDR). The rate of aggregation of washed platelets induced by ADP or ionophore A23187 was decreased in SDR as compared to asymptomatic littermates. The activity of soluble cGMP-PDE was increased in SDR, while no significant difference was observed between SDR and control in soluble and particulate cAMP-PDE activities nor in particulates cGMP-PDE activity. Furthermore, a kinetic study of soluble cGMP-PDE in platelets demonstrated that the apparent Km was lower while the Vmax was higher in SDR. Increases were also observed in the activities of particulate cAMP-PDE and cGMP-PDE at low and high substrate concentrations in liver and heart of SDR. These anomalies of platelet aggregation and cNCL-PDE in SDR were partially correctable by insulin. For comparison, a similar study was performed in streptozotocin-induced diabetic rats (STZ). In contrast to SDR, the rate of platelet aggregation induced by ADP was increased in STZ, and the activity of soluble cGMP-PDE in platelets was decreased in STZ. A similar decrease in the activities of cAMP-PDE in liver was also observed in STZ. This study confirms observations concerning the decrease of cGMP-PDE in tissues of STZ diabetic rats. However, since opposite anomalies in PDE activity as well as a platelet function were observed in another model of diabetes (SDR), the significance of these anomalies in the pathophysiology of diabetes requires further investigation.

Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes

Insulin-stimulated glycogenesis and insulin degradation were studied simultaneously at 37 degrees C in cultured foetal hepatocytes grown for 2-3 days in the presence of cortisol. Degradation of cell-associated insulin, as measured by trichloroacetic acid precipitation, was significant after 4 min in the presence of 1-3 nM-125I-labelled insulin. This process became maximal (30% of insulin degraded) after 20 min, a time when binding-state conditions were achieved. No insulin-degradative activity was detected in a medium that had been exposed to cells. At steady-state, the appearance of insulin degradation products in the medium was linearly dependent on time (1.5 fmol/min per 10(6) cells at 1nM-125I-labelled insulin). Chloroquine (3-50 microM), bacitracin (0.1-10 mM) and NH4Cl (1-10 mM) inhibited insulin degradation as soon as this became detectable and caused an increase in the association of insulin to hepatocytes after 20 min. Lidocaine and dansylcadaverine had similar effects, whereas N-ethylmaleimide, aprotinin, phenylmethanesulphonyl fluoride and leupeptin were found to be ineffective. Chloroquine, and also bacitracin, at concentrations that inhibited insulin degradation, decreased the insulin-stimulated incorporation of [14C]glucose into glycogen over 2 h. This effect of chloroquine was specific, since it did not modify the basal glycogenesis, or the glycogenic effect of a glucose load in the absence of insulin. It therefore appears that the receptor-mediated insulin degradation (or some associated pathway) is functionally related to the glycogenic effect of insulin in foetal hepatocytes.

Insulin degradation. XXVIII. Immunocytochemical localization of glutathione-insulin transhydrogenase in the pancreas, kidney and liver of normal and streptozotocin-diabetic rats and of lean and obese (ob/ob) mice

Glutathione-insulin transhydrogenase catalyzed the inactivation of insulin by splitting the hormone into A and B chains. We have localized this enzyme immunocytochemically by light microscopy in the pancreas, kidney and liver of both lean and obese (ob/ob) mice and similarly in normal and streptozotocin-diabetic rats. Localization was achieved by an antibody to glutathione-insulin transhydrogenase using a peroxidase-antiperoxidase technique. In comparison with tissues from control animals, positive immunostaining for glutathione-insulin transhydrogenase was increased in the obese mouse but reduced in the diabetic rat. Different tissues showed considerable variation in the amount of glutathione-insulin transhydrogenase which could be detected. In the pancreatic islets there was little or no evidence for the presence of the enzyme in peripheral cells. In the kidney, immunocytochemical staining was found only in the proximal tubules. In the liver there was a generalised distribution of the enzyme, but the greatest concentration was in the periportal region. These observations parallel the biochemical data relating to glutathione-insulin transhydrogenase, indicating that different amount of insulin degrading activity exist in different regions of tissues.